59 related articles for article (PubMed ID: 1725549)
1. New concepts in ischemia prevention.
Klein W; Eber B; Dusleag J; Rotman B; Gasser R; Weinrauch V; Brussee H
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S7-14. PubMed ID: 1725549
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
Noll G; Kaufmann U; Wenzel RR; Lüscher TF
Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
Aronow WS
J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
[TBL] [Abstract][Full Text] [Related]
5. Clinical effects of calcium antagonists in silent ischemia.
Pepine CJ
J Cardiovasc Pharmacol; 1990; 16 Suppl 2():S9-12. PubMed ID: 1369708
[TBL] [Abstract][Full Text] [Related]
6. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
Frishman WH; Charlap S
Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
[TBL] [Abstract][Full Text] [Related]
7. [Combination of anti-angina drugs].
Silber S
Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
[TBL] [Abstract][Full Text] [Related]
8. Influence of calcium channel antagonist therapy on the ischemic response to acute coronary occlusion in humans.
Kern MJ
Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III77-85. PubMed ID: 2691144
[TBL] [Abstract][Full Text] [Related]
9. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
10. Effects of antihypertensive therapy on hypertensive heart disease.
Messerli FH; Kaesser UR; Losem CJ
Circulation; 1989 Dec; 80(6 Suppl):IV145-50. PubMed ID: 2532079
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
12. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
Klaus D
Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
[TBL] [Abstract][Full Text] [Related]
13. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
Young JB
Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
[TBL] [Abstract][Full Text] [Related]
15. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment].
Cice G; Di Benedetto A; Tagliamonte E; Ferrara L; Sorice P; Iacono A
Cardiologia; 1997 Apr; 42(4):397-403. PubMed ID: 9244644
[TBL] [Abstract][Full Text] [Related]
17. [Left ventricular diastolic dysfunction in ischemic heart disease. Effects of drug therapy].
Witkowska M
Kardiol Pol; 1992 Dec; 37(12):399-403. PubMed ID: 1363437
[No Abstract] [Full Text] [Related]
18. [Calcium channel inhibitors and ventricular filling].
Dorobantu M; Bounhoure JP
Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1579-85. PubMed ID: 1300955
[TBL] [Abstract][Full Text] [Related]
19. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy.
Mehra MR; Ventura HO; Smart FW; Collins TJ; Ramee SR; Stapleton DD
Am J Cardiol; 1995 Apr; 75(12):853-4. PubMed ID: 7717300
[No Abstract] [Full Text] [Related]
20. Role of calcium channel blockers in experimental exercise-induced ischemia.
Thaulow E; Guth BD; Ross J
Cardiovasc Drugs Ther; 1988 Jan; 1(5):503-12. PubMed ID: 3154679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
